Literature DB >> 15804192

Medical and behavioral symptoms as potential medication side effects in adults with developmental disabilities.

Maria G Valdovinos1, Mary Caruso, Celeste Roberts, Geunyoung Kim, Craig H Kennedy.   

Abstract

The incidence of medical and behavioral symptoms that could occur as side effects of psychotropic medication was assessed in a sample of 30 adults with developmental disabilities. Using a retrospective chart review method, we measured symptoms in six a priori classes of potential side effects over a 2-year period. The majority of side effects involved apparent effects of the psychotropic medications on behavior, mood, or sleep. Different patterns of changes in medication prescription, in relation to recorded side effects, were observed. Overall, there was a significant positive relation between the number of potential side effects recorded and the number of psychotropic medication changes made. Our findings suggest several patterns of side effects associated with psychotropic medication use.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804192     DOI: 10.1352/0895-8017(2005)110<164:MABSAP>2.0.CO;2

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  3 in total

1.  Non-psychiatric health problems among psychiatric inpatients with intellectual disabilities.

Authors:  L Charlot; S Abend; P Ravin; K Mastis; A Hunt; C Deutsch
Journal:  J Intellect Disabil Res       Date:  2011-02

2.  Demonstrating an Analyses of Clinical Data Evaluating Psychotropic Medication Reductions and the ACHIEVE! Program in Adolescents with Severe Problem Behavior.

Authors:  Alison D Cox; Duncan Pritchard; Heather Penney; Llio Eiri; Tim J Dyer
Journal:  Perspect Behav Sci       Date:  2021-02-12

3.  Changes in Stereotypical Behavior Following Chlorpromazine Termination: Polypharmcy Effects on Response Class Membership.

Authors:  Maria G Valdovinos; Marisela Aguilar; Drew Piersma; Alyssa Wilkinson; Craig H Kennedy
Journal:  Adv Neurodev Disord       Date:  2020-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.